Could a simple eye scan spot a dangerous brain condition?
NCT ID NCT05709314
Summary
This study is testing a new dye called AMDX-2011P to see if it can safely help doctors spot signs of cerebral amyloid angiopathy (CAA) in the back of the eye. Researchers will give a single dose of the dye to 25 participants with CAA and then take pictures of their retinas. The main goals are to check the dye's safety and see if it makes harmful protein deposits in the eye easier to see, which could lead to a simpler way to monitor the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL AMYLOID ANGIOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Associated Retina Consultants
RECRUITINGPhoenix, Arizona, 85020, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.